Antimicrobial drug resistance in urinary tract infections in Indonesia.

Project: Research

Project Details

Description

The aim of the project is to develop efficient and sustainable surveillance strategies for antimicrobial resistance in Indonesia. It implements both conventional and LQAS-based drug resistance surveys in both the outpatient- and the inpatient setting. The project harbors additional add-on studies in the field of AMR surveillance, antimicrobial stewardship, and antibiotics use.

Funding: Netherlands Academy of Science (KNAW)

Project partners: Universitas Padjadjaran, Bandung, Indonesia; University of Sumatera Utara, Medan, Indonesia; Amsterdam University Medical Centers, location AMC

Key findings

Antimicrobial resistance in E. coli and K. peumomiae in UTI is extremely high. None of the the oral antibiotics can be recommended for empirical therapy, leaving Indonesian patients without relevant treatment options.

Lot Quality Assurance Sampling is an efficient and cost-saving strategy for a rapid assessment of AMR prevelance to guide empirical antibiotic treatment.
AcronymSPIN
StatusFinished
Effective start/end date1/01/1331/12/17

Collaborative partners

  • Vrije Universiteit Amsterdam (lead)
  • Amsterdam Institute for Global Health and Development
  • Universitas Padjadjaran, Bandung, Indonesia
  • University of Sumatera Utara, Medan, Indonesia
  • Amsterdam UMC

Keywords

  • urinary tract infection
  • antimicrobial resistance
  • surveillance
  • LQAS

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.